Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Hainan Shuangcheng Pharmaceuticals Co., Ltd.
—
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is led by CEO Jianming Li, employs 474 people, headquartered in Haikou, CN, publicly traded since 2012.
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) stock trades at $8.98 with a market capitalization of $3.58B. The stock is valued at a price-to-earnings (P/E) ratio of 66.38, price-to-book of 8.40, price-to-sales of 11.55. Over the past 52 weeks the stock has ranged between $6.36 and $12.43, and currently trades 27.8% below its 52-week high.
On profitability, Hainan Shuangcheng Pharmaceuticals Co., Ltd. generates a return on equity (ROE) of 9.99%, an operating margin of 15.03%, a net profit margin of 16.51%.
Official website: www.shuangchengmed.com
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) — frequently asked questions
What is Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) stock price today?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. (002693.SZ) is currently trading at $8.98, down 4.67% today.
What is 002693.SZ P/E ratio?
Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s P/E ratio is 66.38. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 002693.SZ return on equity (ROE)?
Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s return on equity (ROE) is 9.99%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Hainan Shuangcheng Pharmaceuticals Co., Ltd.'s market cap?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. has a market capitalization of $3.58B.
Does 002693.SZ pay a dividend?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does 002693.SZ carry?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. has a debt-to-equity ratio of 0.63. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 002693.SZ's profit margin?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. reports a net profit margin of 16.51% — the share of revenue left after every cost, including tax and interest.
What sector is 002693.SZ in?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 002693.SZ listed on?
Hainan Shuangcheng Pharmaceuticals Co., Ltd. trades on SHZ under the ticker 002693.SZ.
What is 002693.SZ's 52-week range?
Over the last year Hainan Shuangcheng Pharmaceuticals Co., Ltd. has traded between $6.36 and $12.43.
Related — Stocks
Popular Stocks
Screens 002693.SZ currently matches
On the figures above, Hainan Shuangcheng Pharmaceuticals Co., Ltd. passes the filters for 8 of our ready-made screens, among them Stocks Under $10, High PE Stocks, Stocks Under $100. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.